📋 Tender Overview
Contract awarded for Supply of human medicines 2025-2026 lot-0011, title: alpha-lipoic acid, description: min q 1350 tablets; max q 1950 tablets lot-0018, title: valproic acid + saruri 300 mg (soft capsules), description: min q 9000 soft gastro-resistant capsules; max q 13000 soft gastro-resistant capsules lot-0019, title: valproic acid + saruri 500 mg, description: min q 13500 extended-release tablets; max q 19500 extended-release tablets lot-0057, title: carbamazepine 300 mg, description: min q 9000 tablets; max q 13000 tablets lot-0086, title: combinations (levodopa + carbidopa) 250mg/25mg, description: min q 1350 tablets; max q 1950 tablets lot-0098, title: combinations (vit b1 + b6 + b12) (neuromultivit), description: min q 9000 tablets; max q 13000 tablets lot-0182, title: levetiracetam 1000 mg, description: min q 5400 tablets; max q 7800 tablets lot-0242, title: propranolol 40 mg tablets, description: min q 450 tablets; max q 650 tablets lot-0250, title: risperidone 1 mg/ml oral solution, description: min q 450 bottles; max q 650 bottles lot-0286, title: adsorbed tetanus vaccine, description: min q 783 doses; max q 1131 doses estimated value excluding vat: 12948.50 ron.Supply of human medicines 2025-2026